Fecal Microbiota Clinical Trial
Official title:
Microbiotic Analysis in Digestive Endocrine Tumors
Incidence of digestive neuroendocrine tumors are increasing. Analysis of individual
microbiota is a way to explore new neoplastic mechanisms, tumor identification and
therapeutic orientations. This prospective pilot study aims to describe fecal bacterial
phylogeny of patients with digestive neuroendocrine tumor.
Bacterial genomic signature will be recorded at initiation of Lanreotide treatment in naive
patient with digestive neuroendocrine tumor (pancreas or small intestine), metastatic or
locally advanced, as well as after one year follow up.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05607745 -
Dietary Counseling Coupled With FMT in the Treatment of Obesity and NAFLD - the DIFTOB Study
|
N/A | |
| Completed |
NCT03497806 -
Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection
|
Phase 2 | |
| Completed |
NCT02500563 -
Exploratory/Proof of Principle Microbiota Study
|
N/A | |
| Completed |
NCT04835727 -
Effect of Semi-vegetarian Diet in Inflammatory Bowel Disease Patients With Clinical Remission
|
N/A | |
| Completed |
NCT02677649 -
Microbiota Diversity and Composition and Polyphenol Bioavailability
|
N/A |